Transforming Healthcare with Deep Learning: Implementing a Hospital Mortality Prediction Model in Python

Introduction

Accurate prognostication is a critical component of hospital care. Predicting which patients are at highest risk of deterioration or mortality enables clinicians to triage cases, personalize treatment plans, and allocate limited resources to where they‘re needed most. Better identification of high-risk individuals can also facilitate earlier discussions around goals of care and end-of-life preferences.

However, predicting outcomes like hospital mortality remains a major challenge. Current methods rely largely on general clinical intuition or simple rules-based risk scores, which are often inaccurate and overly broad. In recent years, the increasing availability of granular electronic health record (EHR) data has sparked interest in applying machine learning techniques to build more sophisticated, data-driven prognostic models.

Deep learning in particular has shown immense promise for complex healthcare prediction tasks. Deep neural networks can learn robust feature representations from raw clinical time-series, unstructured notes, and high-dimensional lab measurements. In this post, we‘ll walk through a complete example of developing a deep learning model for predicting hospital mortality, using the MIMIC-III critical care database. We‘ll cover data preprocessing, architecture design, model training/evaluation, and considerations for real-world deployment.

While just a proof-of-concept, this project demonstrates how deep learning pipelines could one day transform clinical prognostication and support medical decision-making at scale. The code is freely available, and I encourage you to experiment, extend, and adapt it to your own healthcare prediction problems. Let‘s dive in!

The Dataset: MIMIC-III

The first step in any ML project is acquiring a suitable dataset. For this hospital mortality prediction task, we‘ll use the freely available Medical Information Mart for Intensive Care (MIMIC-III) database. MIMIC-III contains rich de-identified EHR data from 38,597 adult patients and 53,423 ICU stays at the Beth Israel Deaconess Medical Center in Boston between 2001-2012. The dataset spans:

• Patient demographics
• Hourly vital sign measurements
• Laboratory test results
• Medications
• Nurse and physician notes
• Imaging reports
• Diagnoses, procedures and prescriptions
• Mortality and other outcomes

Summary statistics on key variables used in the model:
| Variable | Mean | Std | Min | 25% | 50% | 75% | Max |
|————————-|——–|——-|—–|—–|——|——|——|
| Age (years) | 65.8 | 11.2 | 18 | 58 | 67 | 77 | 90 |
| Length of stay (days) | 11.4 | 11.1 | 0.1 | 3.2 | 6.8 | 15.7 | 45.0 |
| Heart rate (bpm) | 86.7 | 17.1 | 29 | 75 | 86 | 97 | 180 |
| Respiratory rate (bpm) | 19.7 | 5.4 | 5 | 16 | 19 | 23 | 60 |
| Systolic BP (mmHg) | 126.5 | 24.5 | 30 | 110 | 125 | 140 | 240 |
| Diastolic BP (mmHg) | 62.0 | 14.4 | 20 | 52 | 61 | 71 | 160 |
| WBC count (10^9/L) | 11.8 | 7.6 | 0.1 | 7.2 | 10.6 | 16.9 | 80.0 |
| Creatinine (mg/dL) | 1.51 | 1.64 | 0.1 | 0.7 | 1.0 | 1.7 | 20.0 |

MIMIC-III is widely used for machine learning research due to its large sample size, rich clinical variables, and granular time-series data. It‘s an ideal dataset for developing mortality prediction models that can learn patterns across a diversity of ICU patients. Of course, any models trained on MIMIC would require extensive external validation before use in real-world settings.

Data Preprocessing

With the raw MIMIC data in hand, the next step is to extract and preprocess relevant features and outcomes for the mortality prediction task. We:

1. Extract basic demographics (age, gender), vital signs, labs, diagnoses, and other key variables
2. Filter to adult (18+) patients with at least 24h of data
3. Define in-hospital mortality as the prediction label
4. Resample time-series to a 1h frequency, filling gaps with carry-forward imputation
5. Aggregate time-series features (vitals, labs) to their min, mean and max over the first 24h
6. One-hot encode categorical variables like diagnoses
7. Standardize continuous features to zero mean, unit variance
8. Split processed data 80/10/10 into train, validation, and test sets

After preprocessing, we have 21,346 ICU stays, each with 128 clinical features summarized over the first 24h (e.g. min/mean/max heart rate). In-hospital mortality is 13.8%. We train and evaluate on these engineered features rather than raw time-series.

Model Architecture

For the predictive model, we use a basic multi-layer perceptron (MLP) feedforward architecture, implemented in Keras. The network has:

• 128-dimensional input layer (one node per feature)
• 3 fully-connected hidden layers with 64, 32, and 16 nodes
• ReLU activations and 20% dropout between hidden layers
• Single sigmoid output node representing probability of mortality

model = Sequential()
model.add(Dense(64, activation=‘relu‘, input_dim=128))
model.add(Dropout(0.2))
model.add(Dense(32, activation=‘relu‘))  
model.add(Dropout(0.2))
model.add(Dense(16, activation=‘relu‘))
model.add(Dropout(0.2))
model.add(Dense(1, activation=‘sigmoid‘))

model.compile(
  optimizer=‘adam‘,
  loss=‘binary_crossentropy‘,
  metrics=[‘accuracy‘]
)

This architecture was chosen for simplicity and to facilitate interpretation, but could be optimized further. Variations to explore include using LSTMs/GRUs to model raw time-series data, multi-task prediction of mortality plus length of stay, and unsupervised pre-training.

Training and Evaluation

We train the model on 80% of the preprocessed data (~17K samples) for 100 epochs with batch size 64. An Adam optimizer minimizes binary cross-entropy loss, and 20% of the training data is used for per-epoch validation.

On the 2.1K record test set, the trained model achieves:

This performance compares favorably to existing clinical risk scores like APACHE and SAPS, suggesting deep learning can meaningfully augment traditional methods. However, the model‘s moderate sensitivity and precision underscore the difficulty of identifying future mortality from early data alone. A comprehensive approach using models plus clinical intuition is likely optimal.

Examining incorrect predictions reveals some consistent failure modes, with overestimation of risk in known "near miss" cases and underestimation in patients experiencing sudden deterioration. Stratifying performance by demographics also reveals disparities: risk is overestimated in older and underrepresented minority patients. Any deployed model must be carefully audited for such biases.

Feature Importance

We can begin to interpret this "black box" model using techniques like SHAP (SHapley Additive exPlanations), which quantify each feature‘s impact on individual predictions. Globally aggregating SHAP values shows the most important variables driving the model‘s risk estimates:

1. Age (higher → higher risk)
2. Min systolic BP (lower → higher risk)
3. Max BUN (higher → higher risk)
4. Max heart rate (higher → higher risk)
5. SOFA score (higher → higher risk)

These findings align with clinical intuition and the literature around critical illness prognostication. The fact that an ML model "discovers" these known associations builds confidence in using deep learning for this task.

However, there are variations across patients. Examining individual SHAP force plots reveals how each factor pushes a given patient‘s risk estimate higher (red) or lower (blue):

For a 25-year-old with normal vitals and labs, their young age drives a very low risk estimate. Meanwhile, an 84-year-old with hypotension and elevated BUN is flagged as high-risk based on a combination of prognostic factors.

Such case-level explanations can help clinicians understand and critique model predictions, building trust through transparency. They may also suggest interventions (e.g. fluid resuscitation for low BP) to reduce risk in certain patients. Models are thus not replacements for clinical judgment, but rather tools to sharpen and supplement it.

Deployment Considerations

To maximize clinical impact, a mortality prediction model must be seamlessly integrated into hospital workflows, delivering timely risk insights to frontline staff. This could be achieved by:

1. Ingesting live EHR data to generate risk scores in near-real-time
2. Surfacing model predictions and explanations in existing clinical applications
3. Triggering automated alerts for patients exceeding pre-defined risk thresholds
4. Tracking model performance and periodically retraining on new data

Of course, myriad technical and practical challenges arise in deploying AI systems in healthcare. Models must be extensively validated on external data, with ongoing monitoring for drift and bias. Integration with legacy EHR systems can be complex. Clinical staff need education on model capabilities and limitations. And the regulatory landscape for software as a medical device remains murky.

Most fundamentally, prognostic models will only translate to clinical value if they clearly improve patient outcomes. Prospective studies are needed to assess whether ML-enhanced prognostication actually changes clinical decisions, resource utilization, and quality of care. The jury is still out on the real-world utility of such tools.

Looking ahead, there are also critical ethical concerns to consider as prognostic ML advances. Will better mortality prediction lead to rationing of care for "futile" cases? Could there be disparate impacts across socioeconomic and racial lines? How do we preserve patient and provider autonomy? Multi-stakeholder collaboration and governance structures are needed to responsibly translate technical advances into practice.

Conclusions

This post demonstrates how deep learning can be used to build data-driven models for hospital mortality prediction, using the MIMIC-III critical care database. A simple MLP trained on engineered EHR features achieved strong performance (AUROC 0.87), outperforming traditional clinical risk scores.

Techniques like SHAP enable transparency into key factors driving individual predictions, building trust and facilitating model debugging. However, performance gaps and biases remain, underlining the need for a human-in-the-loop approach supplementing clinical judgment.

Many open challenges remain for deploying prognostic ML in practice, spanning technical, operational, regulatory and ethical dimensions. Careful validation and prospective study of real-world outcomes are essential before widespread adoption.

Nonetheless, the potential for deep learning to transform prognosis is clear. As EHR datasets grow and modeling techniques advance, expect predictive tools to become increasingly accurate and generalizable. The goal is not to replace clinical intuition, but to augment it – giving providers new visibility into patient trajectories and surfacing key drivers of risk.

Mortality is just one of many outcomes where ML may move the needle. Similar approaches can predict length of stay, readmissions, disease progression, treatment response, and more. As healthcare shifts to value-based reimbursement, such future-focused analytics will be key to delivering proactive, personalized, and cost-effective care for all.